Loading resource…

Dr. Frank Post
The appendix provides detailed supplementary information for the study titled 'Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial)'. It includes various tables and figures that present clinical site information, viral load data, adverse events, and statistical analysis plans. This document is intended to support the findings of the main trial publication by offering comprehensive data that was peer-reviewed and is relevant for understanding the trial's outcomes.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

World Malaria Report 2020
Same clinical topic · Infectious Disease

PRIMER SYPHILIS
Same clinical topic · Infectious Disease

LEISHMANIASIS
Same clinical topic · Infectious Disease

Influenza
Same clinical topic · Infectious Disease

VARICELLA ZOSTER VIRUS INFECTION
Same clinical topic · Infectious Disease

RECENT ADVANCES IN THE TREATMENT OF MALARIA
Same clinical topic · Infectious Disease

DEFINING SEPSIS PAST, PRESENT, AND FUTURE
Same clinical topic · Infectious Disease

RAPID DIAGNOSIS OF SEPSIS AND BLOODSTREAM INFECTIONS
Same clinical topic · Infectious Disease

HIV INFECTION
Same clinical topic · Infectious Disease